Bariatric surgery for weight loss shows greater long-term benefits than GLP-1 medicines

A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist medicines alone.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup